NEPH EBITDA | NEPHROS, INC.

NEPHROS, INC. (NEPH) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income $1.21M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income $97.00K; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income $314.00K; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income $248.00K; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2011-12-31 to 2016-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	$1.21M	(m)	$6.02M	(m)	(m)	$681.00K*	$1.99M	$366.00K	$2.42M	$13.00K
2026-03-31	Reported	(m)	$97.00K	(m)	$5.21M	(m)	(m)	-$1.67M	$2.22M	$346.00K	$2.52M	$0.00
2025-09-30	Reported	(m)	$314.00K	(m)	$4.76M	(m)	(m)	$99.00K*	$1.85M	$338.00K	$2.23M	$3.00K
2025-06-30	Reported	(m)	$248.00K	(m)	$4.42M	(m)	(m)	$994.00K*	$1.62M	$311.00K	$2.20M	$9.00K
2025-03-31	Reported	(m)	$566.00K	(m)	$4.88M	(m)	(m)	$322.00K	$1.72M	$295.00K	$2.25M	$0.00
2024-09-30	Reported	(m)	$206.00K	(m)	$3.52M	(m)	$0.00*	-$623.00K*	$1.37M	$188.00K	$1.72M	$0.00
2024-06-30	Reported	(m)	-$317.00K	(m)	$3.25M	(m)	(m)	-$501.00K*	$1.34M	$254.00K	$1.94M	$0.00
2024-03-31	Reported	(m)	-$200.00K	(m)	$3.52M	(m)	(m)	-$672.00K	$1.33M	$212.00K	$2.14M	$0.00
2023-09-30	Reported	(m)	-$203.00K	(m)	$3.74M	(m)	(m)	$562.00K*	$1.55M	$205.00K	$2.14M	$0.00
2023-06-30	Reported	(m)	-$435.00K	(m)	$3.54M	(m)	(m)	$226.00K*	$1.47M	$221.00K	$2.24M	$0.00
2023-03-31	Reported	(m)	-$306.00K	(m)	$3.70M	(m)	(m)	$276.00K	$1.59M	$239.00K	$2.12M	$0.00
2022-09-30	Reported	(m)	-$1.28M	(m)	$2.41M	(m)	$0.00*	-$170.00K*	$1.65M	$252.00K	$1.74M	$0.00
2022-06-30	Reported	(m)	-$814.00K	(m)	$2.85M	(m)	$103.00K*	-$1.07M*	$1.46M	$273.00K	$1.89M	$0.00
2022-03-31	Reported	(m)	-$1.55M	(m)	$2.16M	(m)	$34.00K	-$1.80M	$1.11M	$372.00K	$2.18M	$0.00
2021-09-30	Reported	(m)	-$802.00K	(m)	$2.58M	(m)	$13.00K*	-$910.00K*	$1.22M	$395.00K	$1.72M	$0.00
2021-06-30	Reported	(m)	-$1.12M	(m)	$2.27M	(m)	$0.00*	-$117.00K*	$991.00K	$487.00K	$1.85M	$0.00
2021-03-31	Reported	(m)	-$1.02M	(m)	$2.74M	(m)	$23.00K	-$55.00K	$1.15M	$556.00K	$2.00M	(m)
2020-09-30	Reported	(m)	-$932.00K	(m)	$2.12M	(m)	$13.00K*	-$1.82M*	$896.00K	$751.00K	$1.54M	$0.00
2020-06-30	Reported	(m)	-$1.60M	(m)	$1.58M	(m)	(m)	-$1.72M*	$682.00K	$836.00K	$1.61M	(m)
2020-03-31	Reported	(m)	-$1.03M	(m)	$2.53M	(m)	(m)	-$1.84M	$1.04M	$563.00K	$1.95M	(m)
2019-09-30	Reported	(m)	-$695.00K	(m)	$3.10M	(m)	(m)	-$614.00K*	$1.28M	$777.00K	$1.79M	(m)
2019-06-30	Reported	(m)	-$868.00K	(m)	$2.31M	(m)	(m)	-$1.33M*	$942.00K	$793.00K	$1.40M	(m)
2019-03-31	Reported	(m)	-$1.30M	(m)	$1.77M	(m)	(m)	-$697.00K	$771.00K	$756.00K	$1.50M	(m)
2018-09-30	Reported	(m)	-$511.00K	(m)	$1.72M	(m)	(m)	-$1.12M*	$772.00K	$352.00K	$1.07M	(m)
2018-06-30	Reported	(m)	-$653.00K	(m)	$1.37M	(m)	(m)	-$1.34M*	$536.00K	(m)	$1.09M	(m)
2018-03-31	Reported	(m)	-$1.12M	(m)	$985.00K	(m)	(m)	-$669.00K	$518.00K	(m)	$1.26M	(m)
2017-09-30	Reported	(m)	-$518.00K	(m)	$916.00K	(m)	(m)	-$713.00K*	$384.00K	(m)	$753.00K	(m)
2017-06-30	Reported	(m)	-$700.00K	(m)	$859.00K	(m)	(m)	(m)	$342.00K	(m)	$880.00K	(m)
2017-03-31	Reported	(m)	-$605.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$770.00K	(m)
2016-09-30	Reported	(m)	-$637.00K	(m)	(m)	(m)	$5.00K*	(m)	(m)	(m)	$652.00K	(m)
2016-06-30	Reported	(m)	-$817.00K	(m)	(m)	(m)	$14.00K*	(m)	(m)	(m)	$804.00K	(m)
2016-03-31	Reported	(m)	-$806.00K	(m)	(m)	(m)	$26.00K	(m)	(m)	(m)	$777.00K	(m)
2015-09-30	Reported	(m)	-$1.09M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$974.00K	(m)
2015-06-30	Reported	(m)	-$594.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$735.00K	(m)
2015-03-31	Reported	(m)	-$806.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$843.00K	(m)
2014-09-30	Reported	(m)	-$681.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$765.00K	(m)
2014-06-30	Reported	-$633.00K*	-$636.00K	$3.00K*	(m)	(m)	(m)	(m)	(m)	(m)	$700.00K	(m)
2014-03-31	Reported	-$560,000.00	(m)	(m)	(m)	-118.39%	(m)	(m)	(m)	(m)	$711.00K	(m)
2013-12-31	Reported	-$1.07M	(m)	(m)	(m)	-473.45%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$606.00K*	-$608.00K	$2.00K*	(m)	(m)	(m)	(m)	(m)	(m)	$578.00K	(m)
2013-06-30	Reported	-$625.00K*	-$628.00K	$3.00K*	(m)	(m)	(m)	(m)	(m)	(m)	$660.00K	(m)
2013-03-31	Reported	-$1.01M	(m)	(m)	(m)	-193.09%	(m)	(m)	(m)	(m)	$1.05M	(m)
2012-12-31	Reported	-$1.11M	(m)	(m)	(m)	-301.36%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$852.00K*	-$853.00K	$1.00K*	(m)	(m)	$0.00*	(m)	(m)	(m)	$1.01M	(m)
2012-06-30	Reported	-$809.00K*	-$812.00K	$3.00K*	(m)	(m)	(m)	(m)	(m)	(m)	$838.00K	(m)
2012-03-31	Reported	-$554,000.00	(m)	(m)	(m)	-103.94%	(m)	(m)	(m)	(m)	$720.00K	(m)
2011-09-30	Reported	(m)	-$425.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$574.00K	(m)
2011-06-30	Reported	(m)	-$598.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$660.00K	(m)
2011-03-31	Reported	(m)	-$646.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$729.00K	(m)
2010-09-30	Reported	(m)	-$393.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$550.00K	(m)
2010-06-30	Reported	(m)	-$366.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$545.00K	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	$1.15M	(m)	$18.79M	(m)	(m)	$1.60M	$7.16M	$1.34M	$9.00M	$12.00K
2024-12-31	Reported	(m)	$6.00K	(m)	$14.16M	(m)	$55.00K	-$492.00K	$5.44M	$906.00K	$7.68M	$15.00K
2023-12-31	Reported	(m)	-$1.59M	(m)	$14.24M	(m)	$75.00K	$827.00K	$5.83M	$873.00K	$8.91M	$0.00
2022-12-31	Reported	(m)	-$4.33M	(m)	$9.97M	(m)	$137.00K	-$3.23M	$5.24M	$1.25M	$7.59M	$0.00
2021-12-31	Reported	(m)	-$3.25M	(m)	$10.22M	(m)	$36.00K	-$1.42M	$4.58M	$1.50M	$7.20M	$0.00
2020-12-31	Reported	(m)	-$4.28M	(m)	$8.56M	(m)	$239.00K	-$6.90M	$3.65M	$2.76M	$6.47M	(m)
2019-12-31	Reported	(m)	-$3.15M	(m)	$10.33M	(m)	$14.00K	-$2.28M	$4.25M	$3.09M	$6.12M	-$225.00K
2018-12-31	Reported	(m)	-$3.02M	(m)	$5.69M	(m)	(m)	-$3.66M	$2.48M	$1.54M	$4.52M	-$93.00K
2017-12-31	Reported	(m)	-$2.23M	(m)	$3.81M	(m)	(m)	-$77.00K	$1.52M	(m)	$3.30M	-$1.79M
2016-12-31	Reported	-$2.85M	(m)	(m)	(m)	-122.84%	$45.00K	(m)	(m)	(m)	$2.85M	(m)
2015-12-31	Reported	-$3.42M	(m)	(m)	(m)	-175.93%	$13.00K	(m)	(m)	(m)	$3.44M	(m)
2014-12-31	Reported	-$2.66M	(m)	(m)	(m)	-152.35%	(m)	(m)	(m)	(m)	$2.87M	(m)
2013-12-31	Reported	-$3.31M	(m)	(m)	(m)	-190.11%	$0.00	(m)	(m)	(m)	$3.07M	(m)
2012-12-31	Reported	-$3.32M	(m)	(m)	(m)	-183.95%	$8.00K	(m)	(m)	(m)	$3.62M	(m)
2011-12-31	Reported	-$2.22M	(m)	(m)	(m)	-100.23%	(m)	(m)	(m)	(m)	$2.64M	(m)
2010-12-31	Reported	(m)	-$1.89M	(m)	(m)	(m)	$30.00K	(m)	(m)	(m)	$2.52M	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Sensus Healthcare, Inc. (SRTS)	United States	$0.048B	-3.24
SANUWAVE Health, Inc. (SNWV)	United States	$0.041B	5.47
Spectral AI, Inc. (MDAI)	United States	$0.052B
Xtant Medical Holdings, Inc. (XTNT)	United States	$0.053B
TELA Bio, Inc. (TELA)	United States	$0.057B	-0.82
InspireMD, Inc. (NSPR)		$0.033B
PAVmed Inc. (PAVM)	United States	$0.031B	-3.00
Glucotrack, Inc. (GCTK)	United States	$0.027B
ACCURAY INC (ARAY)	United States	$0.027B	-0.63
DarioHealth Corp. (DRIO)		$0.066B	-1.39